Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| BA1-H5213 | Human | Human BACE-1 Protein, Tag Free (active enzyme, MALS verified) |  |
|
|
| BA1-H5261 | Human | Human BACE-1 Protein, Fc Tag |  |
|
|
| BA1-H5220 | Human | Human BACE-1 Protein, His Tag (active enzyme, MALS verified) |  |
|
The purity of Human BACE-1, Tag Free (Cat. No. BA1-H5213) is more than 90% and the molecular weight of this protein is around 55-65 kDa verified by SEC-MALS.
The purity of Human BACE-1, His Tag (Cat. No. BA1-H5220) is more than 95% and the molecular weight of this protein is around 55-65 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| TAK-070 | TAK-070 | Phase 1 Clinical | Takeda | Alzheimer Disease | Details |
| LY-2811376 | LY-2811376 | Eli Lilly And Company | Details | ||
| Verubecestat | MK-8931; SCH-900931; J1I0P6WT7T (UNII code) | Merck Sharp & Dohme Corp | Details | ||
| LY-3202626 | LY-3202626 | Phase 2 Clinical | Eli Lilly And Company | Alzheimer Disease | Details |
| Elenbecestat | E-2609; [14C]E2609 | Phase 3 Clinical | Eisai Co Ltd | Alzheimer Disease | Details |
| Lanabecestat | AZD-3293; LY-3314814 | Phase 3 Clinical | Astrazeneca Pharmaceutical Co Ltd | Renal Insufficiency; Alzheimer Disease; Hepatic Insufficiency | Details |
This web search service is supported by Google Inc.
A-Z
